In a world of information overflow and fierce competition make sure your company stands out

When you have a story to tell, we can help you get quality exposure in the trade, business and medical press, building confidence and creating value:

We are a small but experienced and efficient team with a proven track-record.

With more than 30 years’ experience, we know how to work with media and journalists

We have the long-standing and trustworthy relationships with them needed to achieve results

WHY MEDIA?

Industry decision makers regard trade and business press as a key information resource

Following leading international media remains an important component of the industry leader’s toolbox for gathering the information they need to make informed business decisions.

Editorial text in trade media is highly credible

A profile or editorial about your company or technology in well-respected trade and business press is far more credible than paid for content or advertising.

Using PR paves the way for your business development efforts

You can reach your potential partners for out-licencing of your projects together with other collaboration partners, investors, or customers with accurate and credible information about your innovations and business offer - thus cost-effectively opening doors for your BD team.

WHO WE ARE

Our team consists of two experts with complimentary backgrounds, skills and experiences.

Ola Björkman is an Associate Professor at Karolinska Institutet since 1985 with 13 years’ experience from the Pharmaceutical Industry and an extensive network within the life science community, built during almost 15 years of work in the interface between industry, academia and society in the Stockholm-Uppsala region.

Richard has more than 25 years of expertise in life sciences PR in Europe and US and has operated and grown both his own companies, one of them becoming HCC Defacto PLC, the third largest biotech agency in Europe in 2003. He has widespread experience in several sub-sectors including oncology and neuroscience, working with therapeutic, diagnostic and medtech companies as well as biotech regions, cancer centres and advocacy groups.

Since 2014, Richard and Ola have formed the team you will meet if you work with us.

MORE ABOUT THE TEAM

WHY US

With more than 30 years experience and long-standing connections with journalists in leading, international trade press, we are passionate about helping small and medium-size life science companies with exciting innovations to succeed.

Large network of journalists

Our network of journalists covers most of the leading, international trade press specializing in Pharma, Biotech and Medtech, as well as other media read by decision makers in industry and healthcare provision. We know key journalists personally, we understand how they work and what they are interested in - invaluable in gaining their attention in an age of information overload.

Current Clients

Our international clients include Cambridge Cognition, Colorcon, Legacy Pharma, Medpharm, MBS, and Leaf Expression Systems. Past clients have ranged from Genzyme and CAT to GSK and J&J. Current and past Nordic clients include the Protein Atlas project, Affibody, Acarix, A1M Pharma, Axis-Shield, Affitech, Follicum, Genetic-Analysisi, Ilya Phrma, Immunovia, Kancera, Lytix Biopharma, Pledpharma, Xbrane, Biovica, PreDiagnostics, Glionova, SciBase and SyntheticMR. We have also conducted projects for Business Sweden, Innovation Norway, Oslo Cancer Cluster, Sweden BIO and Stockholmsmässan (Digital Health Days) and this year (2018), we are official PR partner to NLSDays for the fourth year in a row.

HOW WE WORK

Your business objectives are the starting point

We have the experience to deliver effective PR that supports our client companies irrespective of whether the goal is to secure financing, out-license technology, find a partner or support marketing. We don’t have a standard package for our services. Instead it is always the business objectives which define a tailor-made offer aimed at building value for the client.

Our operational tool-box